0.7147
1.23%
-0.0089
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LXRX Giù?
Forum
Previsione
Frazionamento azionario
Lexicon Pharmaceuticals Inc Azioni (LXRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
60.97%
1.13
|
0.702 | 0.162 | 0.317 | -62.31 |
Cost Of Revenue |
55.71%
0.031
|
0.07 | 0.007 | 0.008 | - |
Gross Profit |
73.89%
1.099
|
0.632 | 0.155 | 0.309 | 0.023 |
Operating Expenses
|
1.98%
46.43
|
47.37 | 49.79 | 44.55 | -31.17 |
Benefits Costs and Expenses |
2.06%
46.46
|
47.44 | 49.79 | 44.56 | -30.37 |
Costs And Expenses |
2.06%
46.46
|
47.44 | 49.79 | 44.56 | -31.17 |
Operating Income/Loss |
3.00%
-45.33
|
-46.74 | -49.63 | -44.24 | -31.14 |
Income/Loss From Continuing Operations Before Tax |
3.00%
-45.33
|
-46.74 | -49.63 | -44.90 | -31.93 |
Income/Loss From Continuing Operations After Tax |
2.73%
-48.40
|
-49.76 | -50.52 | -44.90 | -31.93 |
Net Income/Loss
|
2.73%
-48.40
|
-49.76 | -50.52 | -44.90 | -31.93 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,960%
245.39
|
8.018 | 244.93 | 204.78 | 189.01 |
Diluted Average Shares |
2,960%
245.39
|
8.018 | 244.93 | - | - |
Basic Earnings Per Share |
0.00%
-0.20
|
-0.20 | -0.21 | -0.22 | -0.17 |
Diluted Earnings Per Share |
0.00%
-0.20
|
-0.20 | -0.21 | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):